Follow-up on the IFCT-0302 trial
9 Sep 2017
Follow-up on the IFCT-0302 trial
PACIFIC trial of durvalumab for lung cancer
ESMO 2017: CDK4/6 inhibitors from a patient’s perspective
Editor's Choice for August 2017
Editor's Choice for July 17
iManageCancer: Serious Games for Kids
Translational research in breast cancer
New treatments for lung cancer
The unmet needs of cancer survivors
Managment of advanced prostate cancer
Precision medicine: a nurses perspective
Lymphoma highlights from ASCO annual meeting 2017